Home/Drugs By Ailments / Semaglutide

Semaglutide

Uses of Semaglutide

  • Semaglutide is primarily used for the management of type 2 diabetes mellitus. It belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists.
  • It is also indicated to improve glycaemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise, to reduce the risk of major adverse cardiovascular events in patients with established cardiovascular disease, and may help slow the progression of chronic kidney disease in patients with type 2 diabetes.
  • It is also used for long-term weight management in individuals with obesity or overweight with associated comorbidities.

Side effects of Semaglutide

  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Abdominal pain
  • Decreased appetite

How Semaglutide works

  • Semaglutide is a GLP-1 receptor agonist. It mimics the action of the natural incretin hormone GLP-1 by stimulating insulin secretion in a glucose-dependent manner and suppressing glucagon secretion. This helps in lowering blood glucose levels.
  • It also delays gastric emptying and acts on appetite centres in the brain, leading to reduced food intake and body weight.

Certified content

Written By

docImg
Dr. Sachin SinghMedical Team Lead & Reviewer| 7 years

MBBS

Reviewed By

Dr. Mandeep Chadha
Dr. Mandeep ChadhaLead Medical Content Reviewer| 12 years

MBBS, DNB (OBGY)

Expert Advice

Dosage Forms Available

Semaglutide is available in different forms, including subcutaneous injection (pre-filled pen) and oral tablets.

Age and Dose Restrictions

Semaglutide is primarily approved for adults. Certain formulations for weight management may be used in adolescents ≥12 years in specific indications and countries.

Contraindications

Semaglutide is contraindicated in patients with known hypersensitivity to Semaglutide. It should not be used in patients with a personal or family history of medullary thyroid carcinoma or in patients with multiple endocrine neoplasia syndrome type 2. It is also contraindicated in patients with a history of serious hypersensitivity reactions to GLP-1 receptor agonists.

Other Medications to Avoid

Semaglutide may interact with insulin and insulin secretagogues (e.g.,  sulfonylureas), hormone replacement therapy (e.g., levothyroxine), anticoagulants (warfarin), diuretics (e.g., furosemide), and corticosteroids (e.g., prednisolone). Before using any prescription or over-the-counter medicines, you must talk to your doctor first.

Overdose and Missed Dose

  • Overdose of Semaglutide may lead to severe gastrointestinal symptoms such as nausea and vomiting. Supportive management is recommended in such cases.
  • If you forget to take a dose, take it as soon as you remember within the same day. If it is nearly time for the next dose, skip the missed dose and continue with your regular schedule. Do not take an extra dose to make up for a missed one.

Management of Side Effects

  • Most side effects are temporary and generally resolve as the body adjusts to treatment. However, consult your doctor if symptoms persist or worsen.
  • Eating smaller, more frequent meals may help reduce nausea.
  • Maintaining adequate hydration can help manage gastrointestinal symptoms such as diarrhoea or vomiting.

Use in Driving and Operating Machinery

Semaglutide does not usually affect the ability to drive or operate machinery. However, caution is advised when used with other antidiabetic medicines due to the risk of hypoglycaemia.

Use in Pregnancy and Lactation

Semaglutide is not recommended during pregnancy and breastfeeding.  

Caution in Other Conditions

  • Patients with a history of pancreatitis should use Semaglutide with caution, as it may increase the risk of pancreatic inflammation.
  • Patients with a history of gallbladder disease (cholelithiasis) and thyroid tumor risk should also exercise caution while taking Semaglutide.
  • Patients with diabetic retinopathy should be monitored closely, as rapid improvement in blood glucose control may temporarily worsen retinopathy.
  • Patients with severe gastrointestinal disease, including gastroparesis, should exercise caution due to delayed gastric emptying effects.

Special Dietary and Lifestyle Recommendations

  • Following a balanced diet and regular physical activity is essential to improve glycaemic control and support weight management.
  • Avoid high-fat and large meals, as these may worsen gastrointestinal side effects.
  • Maintaining a healthy body weight and adherence to prescribed therapy improve overall treatment outcomes.
  • Regular monitoring of blood glucose levels is recommended to ensure effective control.

Frequently asked questions

Semaglutide begins to lower blood glucose levels within the first week of initiation, although full therapeutic effects may take several weeks as the dose is gradually increased.

Avoid using Semaglutide if you have a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Monitor for symptoms of pancreatitis such as severe abdominal pain. Regular follow-up is recommended to assess glycaemic control and tolerance.

Do not discontinue Semaglutide without consulting your doctor. Stopping treatment may lead to loss of glycaemic control or weight regain.

Patients with kidney or liver impairment should use Semaglutide with caution and under medical supervision, as dose adjustments or monitoring may be required.

Terms & Conditions

List of medicines for Semaglutide

Wegovy 1mg Flextouch Pre Filled Pen 3ml
Wegovy 1mg Flextouch Pre Filled Pen 3ml
Novo Nordisk India Pvt Ltd
Pack of 3 ML
₹11080
MRP ₹13850
20% OFF
Obeda 1mg Pre Filled Pen 3ml With 32g Needles 6
Obeda 1mg Pre Filled Pen 3ml With 32g Needles 6
Dr. Reddys Laboratories Ltd
Pack of 3 ML
₹3360
MRP ₹4200
20% OFF
Obeda 0.25mg/0.5mg Pre Filled Pen 1.5ml With 32g Needles 6
Obeda 0.25mg/0.5mg Pre Filled Pen 1.5ml With 32g Needles 6
Dr. Reddys Laboratories Ltd
Pack of 1.5 ML
₹3360
MRP ₹4200
20% OFF
Rybelsus 3mg Tablet 10
Rybelsus 3mg Tablet 10
Novo Nordisk India Pvt Ltd
Pack of 10 Units
₹2496.38
MRP ₹2971.88
16% OFF
Rybelsus 14mg Tablet 10
Rybelsus 14mg Tablet 10
Novo Nordisk India Pvt Ltd
Pack of 10 Units
₹2902.5
MRP ₹3628.12
20% OFF
Poviztra Flextouch Pre Filled Pen 0.5mg Combipack 1.5ml With Disposable Needles 4
Poviztra Flextouch Pre Filled Pen 0.5mg Combipack 1.5ml With Disposable Needles 4
Emcure Pharmaceuticals Ltd
Pack of 1.5 ML
₹8400
MRP ₹10500
20% OFF
Wegovy 2.4mg Flextouch Pre Filled Pen 3ml
Wegovy 2.4mg Flextouch Pre Filled Pen 3ml
Novo Nordisk India Pvt Ltd
Pack of 3 ML
₹13940
MRP ₹16400
15% OFF
Rybelsus 7mg Tablet 10
Rybelsus 7mg Tablet 10
Novo Nordisk India Pvt Ltd
Pack of 10 Units
₹2640
MRP ₹3300
20% OFF

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Registered Office Address

Intellihealth Solutions Private Limited
Unit-301 & 304, Lightbridge Tunga Village, Saki Vihar Rd, Chandivali, Powai, Mumbai, Maharashtra, India, 400072.
CIN: U62099MH2019PTC320566
Telephone:09240250346

Grievance Officer

Name: Kishor Kumar

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Playstore
Apple App  Store

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v4.21.6

copyright

2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.

Trust Certified

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner